Drug details
Contrave (naltrexone hcl and bupropion hcl extended-release tablets)
type of Opioid Antagonists
Contrave (naltrexone HCl and bupropion HCl) Extended-release is a combination of an opioid antagonist and an antidepressant used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m2 greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).
This drug may have the following side effects:
- nausea,
- headache,
- dizziness,
- vomiting,
- diarrhea,
- constipation,
- tremor,
- dry mouth,
- trouble sleeping (insomnia),
- rash,
- anxiety,
- increased sweating,
- flu symptoms,
- ringing in the ears,
- fainting.
- abdominal pain,
- changes in taste,
- urinary tract infection,
- hot flashes,
- palpitations,
- fatigue,
- high blood pressure,
- muscle strain,
- problems with attention,
- lightheadedness, or
The following drugs are related to Contrave, either as a replacement or used together:
- Belviq (lorcaserin hydrochloride)
- Belviq XR (lorcaserin hydrochloride extended release tablets)
- Imcivree (setmelanotide injection, for subcutaneous use)
- Saxenda (liraglutide [rdna origin]) injection)
- Xenical (orlistat 120 mg)
- Qsymia (phentermine and topiramate)
- Plenity (superabsorbent hydrogel particles in capsules)
- Wegovy (semaglutide injection)